Posted: January 11th, 2017
DSM IP Assets B.V. v. Novozymes A/S, PI Judge of the District Court of The Hague, The Netherlands, 6 January 2017, Case No. ECLI:NL:RBDHA:2017:110 DSM holps a patent entitled ‘Enzyme preparation yielding a clean taste’. During Opposition, the patent was limited to milk sterilised at ultra high temperatures (‘UHT milk’). An appeal at the TBA […]
READ MOREPosted: November 15th, 2016
Abbott Products Operations AG v. Kern Pharma S.L., Court of Appeals (15th Division) of Barcelona, Spain, 15 September 2016, Docket No. 163/2016. In a Decision rendered on 15 September 2016, the Court of Appeals of Barcelona granted the interim injunctions requested by Abbott against Kern Pharma’s generic Fenofibrate 145 mg. The Court reversed the previous […]
READ MOREPosted: August 1st, 2016
Astrazeneca AB v. Sandoz B.V., PI judge of the District Court of The Hague, 27 July 2016, Case No. ECLI:NL:RBDHA:2016:8700 There is too much doubt that Claim 1 of the Patent in suit will be declared invalid in proceedings on the merits due to lack of inventive step. The requested preliminary injunction therefore will be […]
READ MOREPosted: June 21st, 2016
* Now including an English translation of the judgment * Basic Holdings ULC v. Ruby Decor B.V., Aparto B.V., District Court The Hague, The Netherlands, 4 May 2016, ECLI:NL:RBDHA:2016:4657, with thanks to Alexander Tsoutsanis, DLA Piper (NL) for sending in the English translation Basic Holdings, part of the Glen Dimplex Group, is proprietor of EP […]
READ MOREPosted: June 17th, 2016
B. Braun Melsungen AG v. Becton Dickinson B.V. and Becton Dickinson Infusion Therapy B.V., District Court The Hague (PI proceedings), the Netherlands, Case no. ECLI:NL:RBDHA:2016:6803 The Dutch PI judge ruled that B. Braun had lost its urgent interest needed for obtaining a preliminary injunction after it awaited the outcome of (appeal in) opposition proceedings before […]
READ MOREPosted: May 23rd, 2016
LEO Pharma v. Sandoz, District Court The Hague (PI Proceedings), the Netherlands, 11 May 2016, ECLI:NLRBDHA:2016:5093 LEO Pharma is the proprietor of EP 2 455 083 B1 for a “Pharmaceutical composition for dermal use comprising calcipotriol and betamethasone”, which claims (in claim 1, a combination preparation consisting of calcipotriol, betamethasone and a solvent, used for […]
READ MOREPosted: April 7th, 2016
Novartis AG v. Teva B.V. et al. PI Judge District Court The Hague, The Netherlands, 30 March 2016, C/09/500844 / KG ZA 15-1829 Preliminary injunction proceedings re SPC. A pediatric extension is also available for medicines that earlier recieved an orphan drug status. Teva infringes. A copy of the decision (in Dutch) is available here.
READ MORE
EMAIL US
